| Title |
Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease - a randomized, multicenter, double-blind, placebo-controlled study
|
|---|---|
| Published in |
BMC Pulmonary Medicine, October 2014
|
| DOI | 10.1186/1471-2466-14-158 |
| Pubmed ID | |
| Authors |
Henrik Watz, Felix Krippner, Anne Kirsten, Helgo Magnussen, Claus Vogelmeier |
| Abstract |
Indacaterol is a long-acting beta-2 agonist for once-daily treatment of COPD. We evaluated the effects of indacaterol 150 μg on lung hyperinflation compared with placebo and open-label tiotropium 18 μg. We measured physical activity during treatment with indacaterol 150 μg and matched placebo. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ecuador | 1 | 14% |
| United Kingdom | 1 | 14% |
| Belgium | 1 | 14% |
| Argentina | 1 | 14% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 71% |
| Scientists | 1 | 14% |
| Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 1% |
| Netherlands | 1 | 1% |
| Unknown | 81 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 13 | 16% |
| Student > Master | 11 | 13% |
| Other | 10 | 12% |
| Student > Bachelor | 9 | 11% |
| Student > Ph. D. Student | 9 | 11% |
| Other | 13 | 16% |
| Unknown | 18 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 31 | 37% |
| Nursing and Health Professions | 9 | 11% |
| Agricultural and Biological Sciences | 7 | 8% |
| Sports and Recreations | 3 | 4% |
| Biochemistry, Genetics and Molecular Biology | 2 | 2% |
| Other | 12 | 14% |
| Unknown | 19 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2014.
All research outputs
#7,166,946
of 25,153,613 outputs
Outputs from BMC Pulmonary Medicine
#550
of 2,234 outputs
Outputs of similar age
#71,218
of 260,593 outputs
Outputs of similar age from BMC Pulmonary Medicine
#8
of 32 outputs
Altmetric has tracked 25,153,613 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 2,234 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 260,593 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.